Approval · Notice of Compliance 15127 · 2014
ELIDEL: Notice of Compliance 15127
Issued January 17, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15127
- Date
- January 17, 2014
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specifications for the drug product tests and acceptance criteria involving relaxation of an acceptance criterion
- Therapeutic class
- Topical calcineurin inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ELIDEL | Not yet assigned | — |
Medicinal ingredients
- PIMECROLIMUS 1 PER